title: Sublingual apomorphine and Parkinson's disease.
authors.forename: A J
authors.initials: AJ
authors.lastname: Lees
authors.forename: J L
authors.initials: JL
authors.lastname: Montastruc
authors.forename: N
authors.initials: N
authors.lastname: Turjanski
authors.forename: O
authors.initials: O
authors.lastname: Rascol
authors.forename: B
authors.initials: B
authors.lastname: Kleedorfer
authors.forename: H
authors.initials: H
authors.lastname: Peyro Saint-Paul
authors.forename: G M
authors.initials: GM
authors.lastname: Stern
authors.forename: A
authors.initials: A
authors.lastname: Rascol
mesh_terms: D000286:Administration, Sublingual; D000368:Aged; D001058:Apomorphine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D001058:Apomorphine